Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
A Study to identify toxicity and optimal photodynamic treatment parameters using the
photosensitizer 2-[1-hydroxyethyl]-2-devinylpyropheophorbide-a (HPPH) in high grade
dysplasia, carcinoma-in-situ, or early adenocarcinoma in Barrett's esophagus.